Clinical Trial Update: The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery [Phase 3]

View source ↗

Summary

The ZEro PLASma Trial (ZEPLAST) is a Phase 3 study evaluating avoidance of fresh frozen plasma in cardiac surgery. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Snippet

Sponsor: IRCCS Policlinico S. Donato | Conditions: Heart Disease | Phase 3 | Status: COMPLETED